Genalyte

company

About

Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$50M
Industries
Biotechnology,Health Care,Hospital
Founded date
Jan 1, 2007
Number Of Employee
51 - 100
Operating Status
Active

Genalyte, Inc. is a life sciences company developing and commercializing innovative next-generation multiplexing technology. Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Genalyte has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Jan 11, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 11, 2021 Series Unknown $50M 1 Verily Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Genalyte is funded by 1 investors. Verily are the most recent investors.
Investor Name Lead Investor Funding Round
Verily Yes Series Unknown